Pharmaceuticals Wholesaling in Australia - Industry Market Research Report


February 19, 2013
38 Pages - SKU: IBSS5030954
License type:
The World Market for Pain Management Drugs and Devices
5/20/2013 | published by: Kalorama Information
The World Market for Pain Management Drugs and Devices encompasses a wide variety of products that treat and ease pain. The field of pain management is currently experiencing a busy and interesting period; and  |  read more...
$3,500.00
The World Market for Catheters (Cardiovascular, Urological, Intravenous and Specialty Devices)
5/8/2013 | published by: Kalorama Information
The World Market for Catheters (Cardiovascular, Urological, Intravenous and Specialty Devices) Catheters make it possible to drain or inject fluids or enable access to the body by surgical instruments.  |  read more...
$3,500.00
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
5/8/2013 | published by: Kalorama Information
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis,  |  read more...
$4,500.00
The World Market for Dialysis Equipment and Services (United States, Japan, UK, Italy, India, China, Australia and Canada )
4/15/2013 | published by: Kalorama Information
This report looks at both the equipment and service aspects of the dialysis industry. The industry enjoys a unique place in the healthcare sector. The industry encompasses two very lucrative segments -- the medical device  |  read more...
$3,995.00
Ready-to-use Business Plan To Develop Dental Clinic In Russia.
5/9/2013 | published by: Euroresearch & Consulting
Purpose of this report was to develop a Ready-to-use Business Plan To Develop Dental Clinic In Russia. Please pay attention: Benefits of buying the report: The  |  read more...
$2,450.00
Switzerland Pharmaceuticals and Healthcare Report Q2 2013
5/8/2013 | published by: Business Monitor International
BMI View: While the patent cliff and the consequent availability of generic drugs, as well as price cuts ongeneric medicines and their increasing affordability, will work towards increasing the consumption ofgeneric medicines in Switzerland, BMI  |  read more...
$1,175.00
Australia Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
BMI View: As a developed market, Australia represents opportunities for risk averse pharmaceuticalinvestors, given its ageing and generally affluent population. Importantly, the government is implementingcost-cutting measures to cope with escalating healthcare costs, therefore generic drugmakers  |  read more...
$1,175.00
Cameroon Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
BMI View: Despite the strong growth potential of its pharmaceutical market, we believe Cameroon isunlikely to be of significant interest to multinational pharmaceutical firms. The country's shortcomingsinclude poor public health provision and rampant corruption. Consequently  |  read more...
$1,175.00
Namibia Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
BMI View: We expect Namibia's negative pharmaceutical trade balance to widen as demand for medicinescontinues to be met by imports, and poor local manufacturing sees exports contract in the medium term.Headline Expenditure Forecasts Pharmaceuticals: NAD2.20bn  |  read more...
$1,175.00
Nigeria Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
Executive Summary BMI View: Boosting bilateral co-operation between Nigerian buyers and Indian drugmakers will directlyobstruct the Nigerian government's goal to increase self-sufficiency in medicines production. We do notbelieve implementing a selected import ban on pharmaceuticals should  |  read more...
$1,175.00